Cite
PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression.
MLA
Filippone, A., et al. “PD1/PD-L1 Immune Checkpoint as a Potential Target for Preventing Brain Tumor Progression.” Cancer Immunology, Immunotherapy, vol. 71, no. 9, Sept. 2022, pp. 2067–75. EBSCOhost, https://doi.org/10.1007/s00262-021-03130-z.
APA
Filippone, A., Lanza, M., Mannino, D., Raciti, G., Colarossi, C., Sciacca, D., Cuzzocrea, S., & Paterniti, I. (2022). PD1/PD-L1 immune checkpoint as a potential target for preventing brain tumor progression. Cancer Immunology, Immunotherapy, 71(9), 2067–2075. https://doi.org/10.1007/s00262-021-03130-z
Chicago
Filippone, A., M. Lanza, D. Mannino, G. Raciti, C. Colarossi, D. Sciacca, S. Cuzzocrea, and I. Paterniti. 2022. “PD1/PD-L1 Immune Checkpoint as a Potential Target for Preventing Brain Tumor Progression.” Cancer Immunology, Immunotherapy 71 (9): 2067–75. doi:10.1007/s00262-021-03130-z.